FDA clears HeartFlow's virtual modeling software

By AuntMinnie.com staff writers

September 12, 2019 -- The U.S. Food and Drug Administration (FDA) has cleared cardiovascular software developer HeartFlow's HeartFlow Planner, a real-time virtual modeling software application for coronary artery disease (CAD) intervention.

The software enables interventional cardiologists to model clinical scenarios, explore treatment strategies for patients with CAD before each procedure, and review cases with colleagues, the company said. It is based on the company's HeartFlow Analysis, a color-coded 3D model of a patient's coronary arteries.

HeartFlow plans to highlight HeartFlow Planner at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco.

Copyright © 2019 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking